丁特

丁特丁特
  1. 方法:1.选择32名健康男性志愿受试者,随机分为3组,分别单次口服异丁司特缓释胶囊5mg、10mg和20mg。

    Methods : LA single oral dose of 5 mg , 10 mg and 20 mg of ibudilast sustained release capsule were given to 24 healthy volunteers in a randomized study .

  2. 异丁司特治疗类固醇抵抗性变应性鼻炎的临床研究

    Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis

  3. 以异丁司特缓释胶囊为标准参比制剂,异丁司特缓释片的相对生物利用度为102.6%。

    The relative bioavailability of KC-404 sustained release tablets was 102.6 % .

  4. 以日本杏林公司产品作为参比制剂,国产异丁司特缓释胶囊的人体相对生物利用度为(95.6±11.0)%。

    The relative bioavailability of domestic sustained release capsules of ibudilast is ( 95.6 ± 11.0 ) % .

  5. 目的研究异丁司特缓释片和缓释胶囊在健康人体内的药物动力学和生物利用度。

    Objective To study the pharmacokinetics and relative bioavailability of KC-404 sustained release tablets and capsules in healthy volunteers .

  6. 结论:异丁司特缓释胶囊是一种安全有效的治疗支气管哮喘和慢性喘息性支气管炎的药物。

    Conclusion : Ibudilast su stained-release capsule is an effective agent for treatment of asthma or chronic asthmatic bronchitis .

  7. 目的:评价异丁司特缓释胶囊治疗支气管哮喘和慢性喘息性支气管炎的疗效和安全性。方法:采用双盲双模拟随机平行对照临床试验。

    Objective : To evaluate the efficacy and safety of ibudilast sustained release capsule in treatment of asthma or chronic asthmatic bronchitis .

  8. 这种未来感十足的房屋是水下住宅设计公司克莱因丁斯特集团耗时近2万小时研究、设计和建造出来的。

    The futuristic homes are the result of nearly 20000 hours of research , design and engineering by sub-aquatic home designer Kleindienst Group .

  9. 异丁司特缓释胶囊随机双盲双模拟治疗支气管哮喘或喘息性支气管炎

    A double blind , double dummy , randomized , controlled trial of ibudilast sustained release capsule in treatment of asthma or chronic asthmatic bronchitis

  10. 克莱因丁斯特集团刚刚被批准建造42所别墅,别墅价格还有待商榷,作为世界岛项目的一部分,每个别墅在阿拉伯湾都有属于自己的一块地。

    Kleindienst Group have just been given the green light for 42 villas , the price of which is yet to be determined , that will each have their own plot in the Arabian Gulf as part of the World Islands Project .